Assessment of right ventricular function in acute pulmonary embolism - 18/04/17
the
PROTECT investigators
Background |
The optimal approach to assess right ventricular (RV) function in patients with acute symptomatic pulmonary embolism (PE) lacks clarity.
Methods |
This study aimed to evaluate the optimal approach to assess RV function in normotensive patients with acute symptomatic PE. Outcomes assessed through 30-days after the diagnosis of PE included all-cause mortality and complicated course.
Results |
Eight hundred forty-eight patients were enrolled. Multidetector computed tomography (MDCT) and transthoracic echocardiography agreed on the presence or absence of RV overload in 449 (53%) patients. The combination of the simplified Pulmonary Embolism Severity Index (sPESI) and MDCT showed a negative predictive value for 30-day all-cause mortality of 100%. Of the 43% that had an sPESI of >0 points and MDCT RV enlargement, 41 (11.3%) experienced a complicated course that included 24 (6.6%) deaths. One hundred twenty-nine patients (15%) had an sPESI of >0 points, MDCT, and echocardiographic RV overload. Of these, 21 (16.3%) experienced a complicated course within the first 30days, and 10 (7.7%) of them died.
Conclusions |
Incorporation of echocardiographic RV overload to the sPESI and MDCT did not improve identification of low-risk PE patients, whereas it improved identification of those at intermediate-high risk for short-term complications.
Le texte complet de cet article est disponible en PDF.Plan
| Sources of funding: FIS 2008 (PI 08200), SEPAR 2008, NM 2010. |
Vol 185
P. 123-129 - mars 2017 Retour au numéro
Article précédent
- Population differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalence
- Redford B. Williams, George D. Bishop, Brett C. Haberstick, Andrew Smolen, Beverly H. Brummett, Ilene C. Siegler, Michael A. Babyak, Xiaodong Zhang, E. Shyong Tai, Jeannette Jen-Mai Lee, Maudrene Tan, Yik Ying Teo, Shiwei Cai, Edmund Chan, Carolyn Tucker Halpern, Eric A. Whitsel, Shawn Bauldry, Kathleen Mullan Harris
- Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
- B. Daan Westenbrink, Marco Alings, Christopher B. Granger, John H. Alexander, Renato D. Lopes, Elaine M. Hylek, Laine Thomas, Daniel M. Wojdyla, Michael Hanna, Matyas Keltai, P. Gabriel Steg, Raffaele De Caterina, Lars Wallentin, Wiek H. van Gilst
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?